feed,title,long_url,short_url
🔐MarketWatch,Revance shares gain 8% after FDA approval of cervical dystonia treatment,http://www.marketwatch.com/news/story/revance-shares-gain-8-after/story.aspx?guid=%7B20C06575%2D04D4%2DB545%2D7248%2DE87E32CD6553%7D&siteid=rss,https://da.gd/1KGwPr
🔐MarketWatch,"BioXcel Therapeutics to cut workforce 58%, stock falls 27%",http://www.marketwatch.com/news/story/bioxcel-therapeutics-cut-workforce-58/story.aspx?guid=%7B20C06575%2D04D4%2DB545%2D7248%2DDFFB3262FFAF%7D&siteid=rss,https://da.gd/qmAsm
